Literature DB >> 33231938

Is remdesivir important in clinical practice as a treatment of COVID-19? A study based on meta-analysis data.

Łukasz Szarpak, Tomasz Dzieciątkowski, Miłosz J Jaguszewski, Jerzy R Ładny, Krzysztof J Filipiak.   

Abstract

Entities:  

Year:  2020        PMID： 33231938     DOI： 10.20452/pamw.15686

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN： 0032-3772


× No keyword cloud information.
  3 in total

1.  Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis.

Authors:  Luiza Szarpak; Krzysztof J Filipiak; Aleksandra Gasecka; Wladyslaw Gawel; Dorota Koziel; Milosz J Jaguszewski; Jaroslaw Chmielewski; Anatolii Gozhenko; Karol Bielski; Pawel Wroblewski; Ivan Savytskyi; Lukasz Szarpak; Zubaid Rafique
Journal:  Cardiol J       Date:  2021-10-13       Impact factor: 2.737

2.  A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19.

Authors:  Luiza Szarpak; Zubaid Rafique; Aleksandra Gasecka; Francesco Chirico; Wladyslaw Gawel; Jacek Hernik; Halla Kaminska; Krzysztof J Filipiak; Milosz J Jaguszewski; Lukasz Szarpak
Journal:  Cardiol J       Date:  2021-07-26       Impact factor: 2.737

3.  Remdesivir shifts circadian rhythmicity to eveningness; similar to the most prevalent chronotype in ADHD.

Authors:  Frank Faltraco; Denise Palm; Andrew Coogan; Adriana Uzoni; Isabell Duwe; Frederick Simon; Oliver Tucha; Johannes Thome
Journal:  J Neural Transm (Vienna)       Date:  2021-07-17       Impact factor: 3.575
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.